Skip to main content
main-content

01.12.2017 | Case report | Ausgabe 1/2017 Open Access

BMC Cancer 1/2017

Uncommon presentation of a rare tumour - incidental finding in an asymptomatic patient: case report and comprehensive review of the literature on intrapericardial solitary fibrous tumours

Zeitschrift:
BMC Cancer > Ausgabe 1/2017
Autoren:
Csilla Czimbalmos, Ibolya Csecs, Miklos Polos, Elektra Bartha, Nikolette Szucs, Attila Toth, Pal Maurovich-Horvat, David Becker, Zoltan Sapi, Zoltan Szabolcs, Bela Merkely, Hajnalka Vago
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s12885-017-3574-0) contains supplementary material, which is available to authorized users.
Abbreviations
MRI
Magnetic resonance imaging
SFT
Solitary fibrous tumour

Background

A solitary fibrous tumour (SFT) is a rare primary tumour most commonly originating from mesenchymal tissue of the pleura. Complete surgical resection is the main treatment if possible. Histological appearance shows spindle-shaped cells and collagen fibres. Immunohistochemical features are vimentin, CD34, CD99 positivity and S-100 protein negativity [ 1]. Although the majority of SFTs generally exhibit clinically benign behaviour, 10–30% of SFTs have been associated with local recurrence or histologic malignancy [ 2, 3]. We have only limited data regarding the manifestation and behaviour of rare extrapleural forms such as cardiac SFT [ 4].

Case presentation

A 37-year-old asymptomatic female patient was referred to our hospital with an enlarged cardiac silhouette found on her screening chest X-ray (Fig. 1, panel d). She had no history of cardiovascular disease. She had a spontaneous abortion 3 years previously, and she is a mother of three children. She has a positive family history of cardiovascular diseases and cancer (lung adenocarcinoma and brain tumour). Physical examination revealed distant heart sounds, a regular rate and rhythm. The echocardiographic examination revealed pericardial effusion and an inhomogeneous mobile mass located in the pericardial sac around the left ventricle (Fig. 2, Additional file 1). Subsequently, cardiac magnetic resonance imaging (MRI) was performed, which showed an intrapericardial, semilunar-shaped mass with a size of 10 × 4 × 9 cm attached to the pulmonary trunk surrounding the aortic root, left atrium and left ventricle (Fig. 3). The tumour had well-demarcated margins and did not invade the blood vessels or myocardium. The caudal part of the tumour was mobile, while its cranial part was fixed to the pulmonary trunk (Additional file 2). The MRI scan detected intermediate signal intensity on proton density-weighted images and high signal intensity on T2-weighted spectral fat saturation inversion recovery (SPIR) images (Fig. 3, panel e, f). Both first-pass perfusion and early and late gadolinium-enhanced (LGE) images showed that the mass was vascularized and showed septated, patchy, inhomogeneous LGE (Fig. 3, panel g, h). Coronary computed tomography angiography (CTA) was performed to see whether the coronary arteries were affected. The coronary CTA proved that coronaries were not invaded by the tumour (Fig. 4). We have evaluated the previous screening chest X-rays of the patient that were acquired during the past 10 years. Based on these chest X-rays, we can conclude that the mass had started to form at least 7 years ago (Fig. 1). No abnormalities were found by the abdominal ultrasound examination, the results of hormone tests were normal, and a hormone-secreting nature of the tumour was excluded. Open heart surgery was indicated through median sternotomy (Fig. 5, panel a, b). The intraoperative findings confirmed the MRI and coronary CTA results. The tumour was intrapericardial, attached to the lateral wall of the pulmonary trunk, 2 cm distal from the commissures of the pulmonary valve. The tumour did not invade any other structures of the heart. Complete resection of the tumour with partial resection of the pulmonary trunk was performed (Fig. 5, panel c) using cardiopulmonary bypass. The pulmonary trunk was reconstructed with a round-shaped bovine pericardial patch (Fig. 5, panel b). The intra- and postoperative course were uneventful. Histological evaluation of the septated, cystic mass revealed tumour cells forming an irregular pattern, the so-called “patternless pattern” (Fig. 6, panel a, b). Immunohistochemically, the cells tested positive for vimentin, CD34, CD99 and STAT6 (Fig. 6, panel c-f) but negative for keratin (AE1-AE3), CD31 and S100. Thus, the diagnosis of a primary cardiac solitary fibrous tumour (SFT) was established. The tumour was classified as non-malignant because of the lack of increased mitotic activity, an intact capsule and no sign of vascular invasion. Regular and long-term clinical and MRI follow-up were indicated (every 6 months in the first year, later annually) because of the risk of late local recurrence. At the 3-year follow-up, the patient had no symptoms, and MRI did not show recurrence of the tumour (Fig. 7). The patient’s clinical history is summarized in a timeline, prepared in accordance with CARE guideline (Additional file 3).
Additional file 1: Transthoracic 2D echocardiography movie in the parasternal long-axis. (MP4 1.76 MB)
Additional file 2: Cine movie MRI images in the short-axis planes. (MP4 440 kb)

Discussion and conclusions

A solitary fibrous tumour (SFT) is a rare spindle cell mesenchymal neoplasm that most commonly originates from the pleura, but for which extrapleural anatomic locations have also been reported (e.g., intraabdominal, meningeal, extracranial of the head and neck, and soft tissue SFT) [ 3, 5]. Primary cardiac SFTs are extremely rare; so far, there are only 11 cases reported in the English literature [ 616]. Additionally, primary pericardial SFT was mentioned in four publications without any specific information regarding the exact location, clinical data, patient symptoms or prognosis [ 1720]. The case reports of primary intrapericardial SFTs reported in the literature are summarized in Table 1. Based on limited data about intrapericardial SFTs, it usually affects middle-aged patients, showing no gender-specific difference in incidence. Only two of them were diagnosed as malignant; in two cases, no information was available about the malignancy. Other than two asymptomatic patients with an incidental diagnosis, all of the reported patients with primary cardiac SFTs were symptomatic. Symptoms may depend on the extent and anatomic location of the tumour, most commonly dyspnoea, fatigue, chest discomfort/distress, palpitation, syncope or peripheral oedema.
Table 1
Case reports of primary intrapericardial SFTs reported in the literature supplemented with our case report
 
Authors
Year
Age
Sex
Symptoms
Origin
Tumour imaging
Malignancy
Follow-up length (imaging modality)
Immuno-histochemical marker
1
Bortolotti U et al. [ 6]
1992
60
M
fatigue, chest discomfort, dyspnoea
AAo, PT
X-ray, echo, CT
Benign
9 m (X-ray, echo)
vimentin+
2
Seqawa D et al. [ 7]
1995
50
F
dyspnoea, palpitation
RV
X-ray,
CT, MRI
NA
19 m (NA)
vimentin+
3
Flemming P et al. [ 8]
1996
53
F
NA
LV
NA
NA
died port HTX
CD34 + vimentin +
4
Andreani SM et al. [ 9]
1998
60
M
exertional dyspnoea
NA
X-ray, CT
Benign
4 y (NA)
NA
5
Corgnati G et al. [ 10]
2004
30
M
peripheral oedema
AAo, PT
X-ray, echo
CT, MRI
Benign
18 m (NA)
NA
6
Bothe W et al. [ 11]
2005
39
F
palpitation
RA
echo
Benign
12 m (echo)
CD34 + vimentin +
7
Croti UA et al. [ 12]
2008
5 m
M
asymptomatic
LA
X-ray, echo
Benign
non-CV death after 6 m (NA)
CD34 +
8
Zhao XG et al. [ 13]
2012
55
M
chest distress, dyspnoea
RA
X-ray, CT
Malignant
died after surgery
CD34 +
9
Taguchi S et al. [ 14]
2013
49
F
asymptomatic
LV
CT, MRI
Malignant
NA
CD34 + vimentin +
CD99 +
10
Bianchi G et al. [ 15]
2013
68
F
dyspnoea, fatigue
LV
echo, CT, MRI
Benign
12 m (echo)
CD34 + vimentin +
Bcl2 +
11
Tamenishi A et al. [ 16]
2013
30
F
syncope
left PA
X-ray, CT
Benign
6y (NA)
CD34 +
12
Our case
2017
37
F
asymptomatic
PT
X-ray, echo,
CT, MRI
Benign
3y (MRI)
CD34 + vimentin +
CD99 + STAT6 +
M male, F female, NA no data available, AAo Ascending aorta, PT pulmonary trunk, RA right atrium, LA left atrium, LV left ventricle, PA pulmonary artery, m months, y years
As a first-line imaging modality, chest X-ray typically shows marked cardiomegaly, and echocardiography could verify an intrapericardial mass and pericardial effusion. MRI can provide additional information about the morphology, location and extent of intrapericardial masses, and it can help to further characterize the tumour tissue. In general, MRI characteristics of SFT vary because of the altering degree of vascularity, cystic degeneration, haemorrhage and necrosis. SFTs usually show intermediate signal intensity on T1-weighted images and variable signal intensity on T2-weighted images [ 2]. In our case, the detailed assessment of the tumour using various MRI sequences and contrast administration showed specific characteristics of extrapleural SFTs including septated, patchy, inhomogeneous LGE. Coronary CT angiography also has an added value in the precise evaluation of the relation with the coronary arteries.
SFT shows characteristic CD34 expression in 95% of the cases, and CD99 can also be positive [ 5]. However, these markers are not specific. According to recent studies, STAT6 is a highly sensitive and specific immunohistochemical marker of SFT [ 21]. Most of the intrapericardial SFTs confirmed vimentin and CD34 positivity; specific STAT6 immunostaining was not yet revealed in intrapericardial SFTs.
Our case confirms the conjecture that intrapericardial SFTs are typically slow-growing masses because, according to the consecutive X-ray images, the intrapericardial mass started to form at least 7 years ago.
Although the majority of SFTs of the thorax are benign and are cured by complete resection, 10–20% are locally aggressive or malignant [ 22]. Malignant histology is strongly associated with recurrence, but some benign SFTs still behave aggressively. The literature data imply a higher risk for the recurrence of extrapleural than that for pleuropulmonary SFT [ 23]; many recurrent SFTs do not respond to treatment. This underscores the need for continued long-term follow-up using a high-resolution, non-invasive imaging technique. In the reported cases, X-ray or echocardiography was used during follow-up, and only two intrapericardial SFT cases were reported with a follow-up longer than 2 years [ 9, 16]. An international registry would be needed to have more detailed information based on long-term follow-up regarding the recurrence tendency of intrapericardial SFTs.
Although intrapericardial SFT is an extremely rare condition, the slow-growth, considerable size of the tumour, and its typical MRI appearance can raise the suspicion of SFT. The “patternless pattern” histopathological finding, vimentin, CD34 and CD99 positivity and specific STAT6 immunostaining can be valuable indicators of this rare mesenchymal tumour. Owing to the high recurrence rate of extrapleural SFTs, long-term follow-up is crucial, and magnetic resonance imaging is a reliable method for the early detection of local recurrence.

Acknowledgements

Not applicable.

Funding

There was no funding for this paper.

Availability of data and materials

All data generated or analysed during this study are included in this published article and its supplementary information files.

Ethics approval and consent to participate

Not applicable as this is not a study.

Consent for publication

Written consent was obtained from the patient for publication of this case report and any accompanying images. The case report was written according to the CARE guideline. A copy of the written consent is available for review by the editor of this journal.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Zusatzmaterial
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2017

BMC Cancer 1/2017 Zur Ausgabe

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise